Generating Pharmaceutical Sales before Marketing Authorization

When a patient has a serious illness and there is no approved drug available, the physician may want to try one which has not been authorized for marketing by national health authorities but has shown promise in clinical trials. European Named Patient Programs, like US compassionate use programs, offer physicians access to pharmaceuticals which have not yet been licensed. However, there is one important difference: in Europe an unlicensed drug can be reimbursed. This presents drug-makers with an opportunity to generate revenues while development is still in-progress.

Significant Revenues Are Possible

The additional revenues can be considerable. For example, Pharmion, a US based company focusing on Oncology and Hematology reported dramatic increases in its Thalidomide sales from $1.9 million in 2Q '03 to $15.3 million in 2Q '04, primarily due to named patient sales in Europe for Multiple Myeloma. Thalidomide sales accounted for approximately 75% of Pharmion's total revenues for the first half of 2004, according to company sources, and were generated while the product awaits marketing approval for this indication. Before receiving European Marketing Approval, Shire's Argylin® for essential thrombocythaemia generated about 5% of its total sales from its European named patient program.

Though thalidomide and Agrylin were licensed in the USA for some indications, pharmaceutical companies do set-up named patient programs and receive full reimbursement for drugs that are not licensed for any indication in any market. Examples include: Insmed's SomatoKine® authorized for named patient use for Primary Lateral Sclerosis, Growth Hormone Insensitivity Syndrome (GHIS) and Severe Insulin Resistance and Protherics' ViperaTAb? authorized for named patient use for adder snake bites.

Other Benefits of Named Patient Programs

A named patient program can speed uptake after official launch. Physicians, who have had experience before launch, via clinical trials or named patient programs, often become early adopters and references for other physicians once the drug is freely circulating.

Named patient programs, like US compassionate use programs, can increase good-will toward the company because they simplify the process of gaining access for patients in critical need. Smaller companies often can not afford the administrative time and costs of shipping drugs around the world before launch. This can lead to frustration and resentment towards a company that many physicians will remember long after a drug is officially on the market. Creating a formal channel eliminates the unfortunate need of denying requests and risking ill-will later.

A named patient program should be considered an important part of a pre-launch program. It increases awareness to a pharmaceutical's existence, creates excitement, generates good-will and speeds penetration of the product after launch.

Frequent Communication is Necessary

If one of the objectives is to generate revenues, setting up a named patient program is just the beginning. In order to achieve success, physicians need to be aware of the product and what they need to do to get it. Typical methods of informing physicians, such as sales rep visits and ads, may not be appropriate because a license is necessary to market a drug. While physicians are used to simply writing a prescription and being done with it, named patient programs require paper-work that some find tedious. Therefore the company needs to create an appropriate communication plan and work closely with the targeted medical community to keep them informed and simplify the process.

Issues to Consider

You have decided to make a named patient program part of your pre-marketing plan, what now?

? Administration: Do you "go it alone" or work with a company that is experienced at administering named patient programs?

There are several experienced organizations that can assist your company by gaining approval, setting-up the program, doing administration and taking care of physical distribution. If your organization is well resourced and has a pipe-line of products that will require named patient programs, it might be worthwhile acquiring the expertise internally. However, if you have few appropriate products or a stream-lined organization, it is probably best to consider outsourcing.

? Communication: You've set up the program, how do you optimize it?

If you do not have an experienced European marketing group, an organization that is familiar in sales and marketing of pharmaceuticals in Europe can help you to maximize participation in the named patient program. A communication plan, if properly developed and implemented can increase product awareness, but communication concerning an unlicensed product must be done appropriately. This plan should ensure that your entire target group:

? Is fully aware of the product AND the program

? Knows what needs to be done to take advantage of the program

? Has an advocate available to guide them through the process

The Author, Dr Gene Emmer, is President of Med Services Europe B.V., a European-based consultancy focused on Sales, Marketing and Business Development of Pharmaceutical, Diagnostic and Medical Products. http://www.MedServicesEurope.com +31648566707

The Pain Factor

Last year I told an acquaintance that at the age... Read More

First Step To Addiction Recovery

The first step to over comming any addiction is to... Read More

4 Reasons to Feel Safe Submitting an Electronic Medical Claim

Electronic Medical ClaimFor years, both practices and patients have had... Read More

10 Reasons To Buy Drugs From An Online Canadian Pharmacy

1. Online Canadian pharmacies offer overall best prices on Canadian... Read More

Vioxx and Bextra Lawsuits Could Tie Up Courts for Years

In September, 2004, pharmaceutical giant Merck voluntarily withdrew its painkilling... Read More

The True Meaning of Alternative Medicine

Alternative medicine is a type of therapeutic practice that is... Read More

Taking The Sting Out Of Bug Bites

(NC)-In most cases insect bites are harmless and if left... Read More

How To Save Money On Prescription Medications

If you are a regular user of prescription medications, you... Read More

Lamisil Side Effects Lawyer: Lamisil Tablet

While the recent Lamisil commercial featuring Digger, a disgusting cartoon... Read More

Lipitor Lawyer: Statin Drugs Cause Muscle Damage in 98%

Doctors have been encouraged to prescribe the cholesterol-lowering drugs called... Read More

A Look At Acid Reflux Treatment

Heartburn is a by-product of digestion, specifically affecting the esophagus... Read More

3 Facts Everyone Should Know About Stem Cells

Cord BloodCord Blood is the blood that remains in the... Read More

Zyprexa - History of the Drug

Since the beginning of mankind, mental illness has played a... Read More

You Are Getting Very Sleepy....The Truth about Hypnosis

A hypnotic "trance" is not something that is foreign to... Read More

NIH Official Altered Drug Study

NIH Official Altered Drug StudyDr. Edmund Tramont, director of the... Read More

The Truth about C Reactive Protein and Cholesterol Lowering Drugs

You might disagree, but hear me out on this...The drug... Read More

Five Secrets of High Blood Pressure Treatment

Thirty percent of human population has a high blood pressure... Read More

Rezulin Liver Failure Causes FDA to Recall Drug

Rezulin, a prescription type 2 diabetes drug has been withdrawn... Read More

Facial Pain: When a Nerve Is a Live Wire

Of all the places in the body that can hurt,... Read More

Tomorrow Well Have Rabbit Feet; Cloning

I am not sure where I'm at with this subject... Read More

Generic Drugs: How They Cost You Less?

If you are wondering why the chemist has charged much... Read More

Exposing the Miracle Cure

It was Saturday morning and while I was making breakfast,... Read More

Naproxen Lawyer: Aleve Recall Consideration

Naproxen belongs to a class of drugs called non-steroidal anti-inflammatory... Read More

Bee Propolis: Synergisitc Health Care for the 21st Centruy

For well over a century modern science has progressed at... Read More

Hypothermia - The Cold Facts

If you ever go to cold countries, you should undoubtedly... Read More